Ethic Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Ethic Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $19,618 - $27,870	-15,570 Reduced 42.28%	21,260 $35,000
Q3 2023 Nov 14, 2023	SELL	$1.61 - $2.54 $180,442 - $284,673	-112,076 Reduced 75.27%	36,830 $66,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $12,633 - $21,609	11,082 Added 8.04%	148,906 $276,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.19 $130,209 - $237,632	108,508 Added 370.13%	137,824 $183,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $12,912 - $27,885	-7,922 Reduced 21.27%	29,316 $49,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $27,183 - $139,270	37,238 New	37,238 $116,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

Stay updated on Ethic Inc. with notifications on news.